3 - DIH HOLDING US, INC. (0001883788) (Issuer)
4 - DIH HOLDING US, INC. (0001883788) (Issuer)
3 - DIH HOLDING US, INC. (0001883788) (Issuer)
SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)
Gainers CNS Pharma (NASDAQ:CNSP) stock rose 109.5% to $2.64 during Thursday's pre-market session. The company's market cap stands at $2.2 million. Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 37.23% to $1.29. The company's market cap stands at $24.3 million. Inspire Veterinary (NASDAQ:IVP) shares moved upwards by 21.37% to $1.59. The company's market cap stands at $1.5 million. Salarius Pharmaceuticals (NASDAQ:SLRX) stock increased by 13.63% to $2.5. The market value of their outstanding shares is at $1.4 million. Absci (NASDAQ:ABSI) stock increased by 13.46% to $3.37. The company's market cap stands at $381.0 million. Traws Pharma (NASDAQ:TRAW) stock increased by 12.32% to $
NORWELL, Mass. and HAAPSALU, Estonia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced that Haapsalu Neurological Rehabilitation Center (HNRC), located in Haapsalu, Estonia, has been appointed as the latest DIH Center of Excellence. Recognized for its pioneering work in neurological rehabilitation, Haapsalu Neurological Rehabilitation C
NORWELL, Mass., Aug. 19, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the quarter ended June 30, 2024, which is the first quarter of fiscal 2025. Recent Highlights Revenue of $16.2 million for the quarter ended June 30, 2024, representing growth of 24% over the prior year periodDevice revenue of $12.3 million and
NORWELL, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2024 fourth quarter and year ended March 31, 2024. Recent Highlights Revenue of $64.5 million for the fiscal year ended March 31, 2024, representing growth of 19% over the prior yearDevice revenue of $51.1 million and serv
S-1/A - DIH HOLDING US, INC. (0001883788) (Filer)
8-K - DIH HOLDING US, INC. (0001883788) (Filer)
8-K - DIH HOLDING US, INC. (0001883788) (Filer)
NORWELL, Mass. and HAAPSALU, Estonia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced that Haapsalu Neurological Rehabilitation Center (HNRC), located in Haapsalu, Estonia, has been appointed as the latest DIH Center of Excellence. Recognized for its pioneering work in neurological rehabilitation, Haapsalu Neurological Rehabilitation C
ZURICH, Switzerland, June 25, 2024 (GLOBE NEWSWIRE) -- DIH HOLDING US, Inc. ("DIH") (NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced that the Zihlschlacht Rehabilitation Clinic, founded in 1891 as a sanatorium, has been appointed as the first DIH Center of Excellence in Switzerland. Located on the Swiss side of Lake Constance, the clinic is renowned for its leadership in treating neurological diseases and its pioneering efforts in neurorehabilitation and research. The DIH Center of Excellence program recognizes strategic partners that showcase best practices in rehabilitation robot
NORWELL, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH") (NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced a strategic partnership with B-Temia Inc. aimed at driving AI-based innovation and smart integral solutions in the rehabilitation market. Leveraging B-Temia's expertise in AI-based robotics development alongside DIH's smart integral solutions and broad robotic portfolios, this collaboration marks a significant step forward in enhancing the quality of life for individuals in need of functional rehabilitation and support. Under this partnership, DIH and B-Tem